Kampala, Uganda | Uganda has renewed efforts to combat malaria as the Uganda Malaria Indicator Survey (UMIS) 2025 was officially launched yesterday, revealing a rise in prevalence from 10 percent in 2018–2019 to 13 percent in 2024–2025.
Dr. Kasonde Mwinga, WHO Uganda Country Representative, highlighted the United States’ continued support, noting the provision of 2.6 million insecticidal mosquito nets, 4.5 million rapid diagnostic tests, 2.2 million treatment doses for uncomplicated malaria, and 200,000 doses for severe cases. She added that indoor residual spraying is being conducted in seven districts of Eastern Uganda, reaching nearly 822,000 households and protecting about 2.9 million people.
The launch coincided with the signing of a historic five-year, $2.3 billion (~UGX 18 trillion) Memorandum of Understanding (MOU) on health cooperation between Uganda and the United States, aimed at strengthening health systems, expanding lifesaving services, and promoting sustainable interventions.
Dr. Chris N. Mukiza, Executive Director of UBOS, said the UMIS 2025 report is the first of eight national statistical products scheduled for release between March and May 2026. He emphasized that the survey provides reliable data to guide policy, programme planning, and resource allocation.
Albert Byamugisha, UBOS Board Chair, noted that the findings will help guide malaria control programmes and strengthen health sector planning. He highlighted progress in under-five mortality, infant survival, and maternal mortality, attributing these gains to sustained health investments and strong collaboration with development partners.
Amos Lugoloobi, Minister of State for Planning, stressed that credible statistics are crucial for policy planning and effective interventions. He noted that the survey’s insights will help the government and partners target high-burden areas, strengthen malaria prevention and treatment, and improve public health outcomes.
The UMIS 2025 report provides key data on malaria prevalence, prevention, and treatment, offering a foundation for evidence-based decisions and interventions to accelerate Uganda’s fight against the disease.